Works matching DE "RISEDRONATE"

Results: 160

Mechanistic insights into protonation state as a critical factor in hFPPS enzyme inhibition.

Published in:

Journal of Computer-Aided Molecular Design, 2015, v. 29, n. 7, p. 667, doi. 10.1007/s10822-015-9853-4

By:

Fernández, David;
Ortega-Castro, Joaquin;
Mariño, Laura;
Perelló, Joan;
Frau, Juan

Publication type:

Article

Effect of Combined Teriparatide and Monthly Risedronate Therapy on Cancellous Bone Mass in Orchidectomized Rats: A Bone Histomorphometry Study.

Published in:

Calcified Tissue International, 2015, v. 97, n. 1, p. 23, doi. 10.1007/s00223-015-0006-5

By:

Iwamoto, Jun;
Seki, Azusa

Publication type:

Article

Increased Bone Mineral Density with Monthly Intravenous Ibandronate Contributes to Fracture Risk Reduction in Patients with Primary Osteoporosis: Three-Year Analysis of the MOVER Study.

Published in:

Calcified Tissue International, 2014, v. 95, n. 6, p. 557, doi. 10.1007/s00223-014-9927-7

By:

Hagino, Hiroshi;
Yoshida, Seitaro;
Hashimoto, Junko;
Matsunaga, Masayuki;
Tobinai, Masato;
Nakamura, Toshitaka

Publication type:

Article

Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis.

Published in:

Calcified Tissue International, 2013, v. 93, n. 2, p. 137, doi. 10.1007/s00223-013-9734-6

By:

Nakamura, Toshitaka;
Nakano, Tetsuo;
Ito, Masako;
Hagino, Hiroshi;
Hashimoto, Junko;
Tobinai, Masato;
Mizunuma, Hideki

Publication type:

Article

A Novel Monthly Dosing Regimen of Risedronate for the Treatment of Postmenopausal Osteoporosis: 2-Year Data.

Published in:

Calcified Tissue International, 2013, v. 92, n. 1, p. 59, doi. 10.1007/s00223-012-9668-4

By:

McClung, Michael;
Benhamou, Claude-Laurent;
Man, Zulema;
Tlustochowicz, Witold;
Zanchetta, Jose;
Eusebio, Rachelle;
Balske, Ana;
Matzkin, Ellen;
Olszynski, Wojciech;
Recker, Robert;
Delmas, Pierre

Publication type:

Article

Trabecular bone score in patients with liver transplants after 1 year of risedronate treatment.

Published in:

Transplant International, 2016, v. 29, n. 3, p. 331, doi. 10.1111/tri.12725

By:

Librizzi, María Soledad;
Guadalix, Sonsoles;
Martínez-Díaz Guerra, Guillermo;
Allo, Gonzalo;
Lora, David;
Jimenez, Carlos;
Hawkins, Federico

Publication type:

Article

Efficacy of discontinuing risedronate for patients with systemic lupus erythematosus: a prospective study.

Published in:

Lupus, 2018, v. 27, n. 10, p. 1636, doi. 10.1177/0961203318784649

By:

Ishida, T.;
Yoshida, S.;
Kimura, Y.;
Fujiki, Y.;
Kotani, T.;
Takeuchi, T.;
Makino, S.;
Arawaka, S.

Publication type:

Article

Risedronate Sodium for the Treatment of Osteoporosis and Paget's Disease: The Evidence of its Therapeutic Value.

Published in:

Clinical Medicine Reviews in Therapeutics, 2012, v. 4, p. 109, doi. 10.4137/CMRT.S3393

By:

Stanford, Phoebe E.;
Center, Jacqueline R.

Publication type:

Article

Powder X-ray diffraction of risedronate sodium hemipentahydrate, C7H10NNaO7P2(H2O)2.5.

Published in:

2014

By:

Kaduk, J.A.;
Crowder, C.E.;
Zhong, K.;
Fawcett, T.G.;
Suchomel, M.R.

Publication type:

Chart/Diagram/Graph

The Therapeutic Effectiveness of the Coadministration of Weekly Risedronate and Proton Pump Inhibitor in Osteoporosis Treatment.

Published in:

Journal of Osteoporosis, 2014, p. 1, doi. 10.1155/2014/607145

By:

Mizue Tanaka;
Soichiro Itoh;
Taro Yoshioka;
Kimihiro Yamashita

Publication type:

Article

Differences in In Vitro Disintegration Time among Canadian Brand and Generic Bisphosphonates.

Published in:

Journal of Osteoporosis, 2014, p. 1, doi. 10.1155/2014/420451

By:

Olszynski, Wojciech P.;
Adachi, Jonathan D.;
Davison, K. Shawn

Publication type:

Article

Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis.

Published in:

Patient Preference & Adherence, 2016, v. 10, p. 523, doi. 10.2147/PPA.S95634

By:

Calabria, S.;
Cinconze, E.;
Rossini, M.;
Rossi, E.;
Maggioni, A. P.;
Pedrini, A.;
De Rosa, M.

Publication type:

Article

Oral bisphosphonates in a postmenopausal population: a systemic review study.

Published in:

Open Access Surgery, 2013, v. 6, p. 37, doi. 10.2147/OAS.S39616

By:

Chia-Chi Chu;
Hirofumi Haga

Publication type:

Article

Clinical utility of risedronate in postmenopausal osteoporosis: patient considerations with delayed-release formulation.

Published in:

International Journal of Women's Health, 2012, v. 4, p. 167, doi. 10.2147/IJWH.S18209

By:

Kinov, Plamen;
Boyanov, Mihail

Publication type:

Article

Pharmacological management of osteoporosis – when to treat and when to stop.

Published in:

Expert Review of Clinical Pharmacology, 2016, v. 9, n. 10, p. 1315, doi. 10.1080/17512433.2016.1203252

By:

Vannucci, Letizia;
Brandi, Maria Luisa

Publication type:

Article

Risedronate extraction from artificial urine with using monolithic polymer-based anion exchangers.

Published in:

Journal of the Iranian Chemical Society, 2019, v. 16, n. 1, p. 93, doi. 10.1007/s13738-018-1484-y

By:

Zielińska, Monika;
Voelkel, Adam

Publication type:

Article

Midterm outcome of risedronate therapy for patients with Paget's disease of bone in the central part of Japan.

Published in:

Clinical Rheumatology, 2013, v. 32, n. 2, p. 241, doi. 10.1007/s10067-012-2109-y

By:

Nishida, Yoshihiro;
Yamada, Yoshihisa;
Tsukushi, Satoshi;
Sugiura, Hideshi;
Urakawa, Hiroshi;
Ishiguro, Naoki

Publication type:

Article

Risedronate-associated scleritis: a case report and review of the literature.

Published in:

Clinical Rheumatology, 2012, v. 31, n. 9, p. 1403, doi. 10.1007/s10067-012-2035-z

By:

Hemmati, Iman;
Wade, John;
Kelsall, John

Publication type:

Article

Perioperative alendronate, risedronate, calcitonin and indomethacin treatment alters femoral stem fixation and periprosthetic bone mineral density in ovariectomized rats.

Published in:

Journal of Orthopaedic Science, 2015, v. 20, n. 4, p. 728, doi. 10.1007/s00776-015-0717-5

By:

Cankaya, Deniz;
Tabak, Yalcin;
Ozturk, Akif;
Gunay, Muhammed

Publication type:

Article

Journal of Bone and Mineral Metabolism Best Paper Award 2020.

Published in:: Journal of Bone & Mineral Metabolism, 2020, v. 38, n. 6, p. 745, doi. 10.1007/s00774-020-01166-2
Publication type:: Article

Skeletal and mineral metabolic effects of risedronate in a rat model of high-turnover renal osteodystrophy.

Published in:

2020

By:

Ishida, Hiroaki;
Komaba, Hirotaka;
Hamano, Naoto;
Yamato, Hideyuki;
Sawada, Kaichiro;
Wada, Takehiko;
Nakamura, Michio;
Fukagawa, Masafumi

Publication type:

journal article

Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis.

Published in:

2020

By:

Soen, Satoshi;
Kishimoto, Hideaki;
Hagino, Hiroshi;
Sone, Teruki;
Ohishi, Hiroaki;
Fujimoto, Tsukasa;
Sasaki, Emma;
Tanaka, Sakae;
Sugimoto, Toshitsugu

Publication type:

journal article

Efficacy and safety of once-monthly risedronate in osteoporosis subjects with mild-to-moderate chronic kidney disease: a post hoc subgroup analysis of a phase III trial in Japan.

Published in:

2019

By:

Sugimoto, Toshitsugu;
Inoue, Daisuke;
Maehara, Masayuki;
Oikawa, Ichiro;
Shigematsu, Takashi;
Nishizawa, Yoshiki

Publication type:

journal article

Factors associated with inadequate responses to risedronate in Japanese patients with osteoporosis.

Published in:

2019

By:

Okazaki, Ryo;
Muraoka, Ryoichi;
Maehara, Masayuki;
Inoue, Daisuke

Publication type:

journal article

Biomaterials Development, Modification, and Potential Application for Interventional Cardiology.

Published in:

BioMed Research International, 2020, p. 1, doi. 10.1155/2020/4890483

By:

Li, Jingan;
De Rosa, Salvatore;
Wang, Juan;
Zhang, Kun

Publication type:

Article

UPLC-UV Method for Determination of Risedronate in Human Urine.

Published in:

Journal of Chromatographic Science, 2014, v. 52, n. 7, p. 713, doi. 10.1093/chromsci/bmt105

By:

Seo, Young Hwan;
Chung, Yoon Hee;
Lim, Cheol-hee;
Jeong, Ji Hoon

Publication type:

Article

Oral risedronate increases Gruen zone bone mineral density after primary total hip arthroplasty: a meta-analysis.

Published in:

Journal of Orthopaedic Surgery & Research, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13018-018-0794-1

By:

Li, Qifeng;
Xu, Baoshan

Publication type:

Article

The efficiency of risedronate in reducing bone resorption after total hip arthroplasty: a meta-analysis of randomized control trials at a minimum of 6 months' follow-up.

Published in:

Journal of Orthopaedic Surgery & Research, 2018, v. 13, n. 1, p. N.PAG, doi. 10.1186/s13018-018-0808-z

By:

Yang, Liqing

Publication type:

Article

Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women.

Published in:

2016

By:

Bilek, Laura D.;
Waltman, Nancy L.;
Lappe, Joan M.;
Kupzyk, Kevin A.;
Mack, Lynn R.;
Cullen, Diane M.;
Berg, Kris;
Langel, Meghan;
Meisinger, Melissa;
Portelli-Trinidad, Ashlee;
Lang, Molly

Publication type:

journal article

The kinetic study of the thermally induced degradation and an evaluation of the drug-excipient interactions performed for a new-generation bisphosphonate—risedronate.

Published in:

Journal of Thermal Analysis & Calorimetry, 2018, v. 134, n. 1, p. 721, doi. 10.1007/s10973-018-7216-9

By:

Vlase, Gabriela;
Albu, Paul;
Doca, Sorin Cristian;
Mateescu, Madalina;
Vlase, Titus

Publication type:

Article

An easy and effective method for synthesis and radiolabelling of risedronate as a model for bone imaging.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2016, v. 59, n. 4, p. 157, doi. 10.1002/jlcr.3384

By:

Motaleb, M. A.;
Adli, A. S. A.;
El ‐ Tawoosy, M.;
Sanad, M. H.;
AbdAllah, M.

Publication type:

Article

Effects of risedronate on the morphology and viability of gingiva-derived mesenchymal stem cells.

Published in:

Biomedical Reports, 2015, v. 3, n. 6, p. 845, doi. 10.3892/br.2015.520

By:

BO-BAE KIM;
YOUNGKYUNG KO;
JUN-BEOM PARK

Publication type:

Article

Surgical treatment of bisphosphonate-associated osteonecrosis of the mandible: Report of two cases.

Published in:

2015

By:

Acikan, İzzet;
Aslan, Necat;
Durmuş, Halil İbrahim;
Atalay, Yusuf;
Atılgan, Serhat;
Yaman, Ferhan

Publication type:

Case Study

Histomorphometric Effects of 2% Risedronate Gel on Calvarial Bone Defects in Rabbits.

Published in:

Journal of Dentistry (2345-6485), 2021, v. 22, n. 1, p. 14, doi. 10.30476/DENTJODS.2020.82926.1032

By:

Aghayan, Shabnam;
Asghari, Ahmad;
Mortazavi, Pejman;
Marzoughi, Shirin

Publication type:

Article

Polyelectrolyte Complex Based Interfacial Drug Delivery System with Controlled Loading and Improved Release Performance for Bone Therapeutics.

Published in:

Nanomaterials (2079-4991), 2016, v. 6, n. 3, p. 53, doi. 10.3390/nano6030053

By:

Vehlow, David;
Schmidt, Romy;
Gebert, Annett;
Siebert, Maximilian;
Lips, Katrin Susanne;
Müller, Martin

Publication type:

Article

Effect on bone turnover markers of once-yearly intravenous infusion of zoledronic acid versus daily oral risedronate in patients treated with glucocorticoids.

Published in:

Rheumatology, 2013, v. 52, n. 6, p. 1058, doi. 10.1093/rheumatology/kes410

By:

Devogelaer, Jean-Pierre;
Sambrook, Philip;
Reid, David M.;
Goemaere, Stefan;
Ish-Shalom, Sophia;
Collette, Julien;
Su, Guoqin;
Bucci-Rechtweg, Christina;
Papanastasiou, Philemon;
Reginster, Jean-Yves

Publication type:

Article

Skapula Tutulumlu Paget Olgusu.

Published in:

Turkish Journal of Osteoporosis / Turk Osteoporoz Dergisi, 2015, v. 21, n. 3, p. 149, doi. 10.4274/tod.60783

By:

Mesci, Nilgün;
Mesci, Erkan;
Külcü, Duygu Geler;
Eroğlu, Pınar Duygu

Publication type:

Article

In vitro evaluation of the effects of risedronate associated with cobalamin on osteoblastic cells.

Published in:

RGO: Revista Gaúcha de Odontologia, 2015, v. 63, n. 2, p. 161, doi. 10.1590/1981-863720150002000042445

By:

FIUZA, Jaqueline Aparecida;
MARTINEZ, Elizabeth Ferreira;
de BRITO JÚNIOR, Rui Barbosa

Publication type:

Article

Spontaneous Incomplete transverse subtrochanteric femoral fracture with cortical thickening possibly secondary to risedronate use: a case report.

Published in:

Journal of Medical Case Reports, 2012, v. 6, n. 1, p. 272, doi. 10.1186/1752-1947-6-272

By:

Alfahad, Anas;
Thet, Ei Mon;
Radwan, Fawzy;
Sudhakar, Joe;
Nini, Khin;
Tachtatzis, Phaedra

Publication type:

Article

Design and Development of Bioceramic Based Functionalized PLGA Nanoparticles of Risedronate for Bone Targeting: In-vitro Characterization and Pharmacodynamic Evaluation.

Published in:

Pharmaceutical Research, 2015, v. 32, n. 10, p. 3149, doi. 10.1007/s11095-015-1692-4

By:

Rawat, Purnima;
Manglani, Kapil;
Gupta, Sarika;
kalam, Abul;
Vohora, Divya;
Ahmad, Farhan;
Talegaonkar, Sushama

Publication type:

Article

No effect of risedronate on articular cartilage damage in the Dunkin Hartley guinea pig model of osteoarthritis.

Published in:

Scandinavian Journal of Rheumatology, 2013, v. 42, n. 5, p. 408, doi. 10.3109/03009742.2013.774046

By:

Thomsen, JS;
Straarup, TS;
Danielsen, CC;
Oxlund, H;
Brüel, A

Publication type:

Article

No effect of risedronate on femoral periprosthetic bone loss following total hip arthroplasty.

Published in:

Acta Orthopaedica, 2015, v. 86, n. 5, p. 569, doi. 10.3109/17453674.2015.1041846

By:

Muren, Olle;
Akbarian, Ehsan;
Salemyr, Mats;
Bodén, Henrik;
Eisler, Thomas;
Stark, André;
Sköldenberg, Olof

Publication type:

Article

The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data.

Published in:

Acta Pharmacologica Sinica, 2015, v. 36, n. 7, p. 841, doi. 10.1038/aps.2015.30

By:

Gu, Jie-mei;
Wang, Li;
Lin, Hua;
Chen, De-cai;
Tang, Hai;
Jin, Xiao-lan;
Xia, Wei-bo;
Hu, Yun-qiu;
Fu, Wen-zhen;
He, Jin-wei;
Zhang, Hao;
Wang, Chun;
Yue, Hua;
Hu, Wei-wei;
Liu, Yu-juan;
Zhang, Zhen-lin

Publication type:

Article

Comparison of concurrent treatment with vitamin K<sub>2</sub> and risedronate compared with treatment with risedronate alone in patients with osteoporosis: Japanese Osteoporosis Intervention Trial-03.

Published in:

2017

By:

Tanaka, Shiro;
Miyazaki, Teruhiko;
Uemura, Yukari;
Miyakawa, Nobuaki;
Gorai, Itsuo;
Nakamura, Toshitaka;
Fukunaga, Masao;
Ohashi, Yasuo;
Ohta, Hiroaki;
Mori, Satoshi;
Hagino, Hiroshi;
Hosoi, Takayuki;
Sugimoto, Toshitsugu;
Itoi, Eiji;
Orimo, Hajime;
Shiraki, Masataka

Publication type:

journal article

Efficacy on the risk of vertebral fracture with administration of once-weekly 17.5 mg risedronate in Japanese patients of established osteoporosis with prevalent vertebral fractures: a 156-week longitudinal observational study in daily practice.

Published in:

2017

By:

Soen, Satoshi;
Umemura, Takashi;
Ando, Tsuyoshi;
Kamisaki, Toshiaki;
Nishikawa, Masahiko;
Muraoka, Ryoichi;
Ikeda, Yoshinori;
Takeda, Kyoko;
Osawa, Mitsuharu;
Nakamura, Toshitaka

Publication type:

journal article

Higher response with bone mineral density increase with monthly injectable ibandronate 1 mg compared with oral risedronate in the MOVER study.

Published in:

2016

By:

Nakano, Tetsuo;
Yamamoto, Masao;
Hashimoto, Junko;
Tobinai, Masato;
Yoshida, Seitaro;
Nakamura, Toshitaka

Publication type:

journal article

Comparison of treatment effects of teriparatide and the bisphosphonate risedronate in an aged, osteopenic, ovariectomized rat model under various clinical conditions.

Published in:

2016

By:

Sugie-Oya, Ayano;
Takakura, Aya;
Takao-Kawabata, Ryoko;
Sano, Hiroko;
Shimazu, Yukari;
Isogai, Yukihiro;
Yamaguchi, Akira;
Ishizuya, Toshinori

Publication type:

journal article

Patient preference for monthly bisphosphonate versus weekly bisphosphonate in a cluster-randomized, open-label, crossover trial: Minodroate Alendronate/Risedronate Trial in Osteoporosis (MARTO).

Published in:

2016

By:

Iwamoto, Jun;
Okano, Hiroya;
Furuya, Takefumi;
Urano, Tomohiko;
Hasegawa, Masaichi;
Hirabayashi, Hisashi;
Kumakubo, Takami;
Makita, Kazuya

Publication type:

journal article

Clinical efficacy of oral risedronate therapy in Japanese patients with Paget's disease of bone.

Published in:

Journal of Bone & Mineral Metabolism, 2015, v. 33, n. 5, p. 584, doi. 10.1007/s00774-014-0623-5

By:

Ohara, Masaya;
Imanishi, Yasuo;
Nagata, Yuki;
Ishii, Akira;
Kobayashi, Ikue;
Mori, Katsuhito;
Ito, Manabu;
Miki, Takami;
Nishizawa, Yoshiki;
Inaba, Masaaki

Publication type:

Article

Risedronate improves bone architecture and strength faster than alendronate in ovariectomized rats on a low-calcium diet.

Published in:

Journal of Bone & Mineral Metabolism, 2014, v. 32, n. 6, p. 653, doi. 10.1007/s00774-013-0543-9

By:

Yano, Tetsuo;
Yamada, Mei;
Konda, Tomoyuki;
Shiozaki, Makoto;
Inoue, Daisuke

Publication type:

Article